Jupiter Neurosciences, Inc.
JUNS
$1.11
-$0.13-10.48%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | 9.49% | -48.40% | -- | -- | -- |
| Gross Profit | -9.49% | 48.40% | -- | -- | -- |
| SG&A Expenses | 22.72% | -10.93% | -- | -- | -- |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 19.65% | -20.20% | -- | -- | -- |
| Operating Income | -19.65% | 20.20% | -- | -- | -- |
| Income Before Tax | 9.16% | 49.00% | -- | -- | -- |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 9.16% | 49.00% | -- | -- | -- |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 9.16% | 49.00% | -- | -- | -- |
| EBIT | -19.65% | 20.20% | -- | -- | -- |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 26.49% | 55.96% | -- | -- | -- |
| Normalized Basic EPS | -2.45% | 24.51% | -- | -- | -- |
| EPS Diluted | 28.13% | 56.21% | -- | -- | -- |
| Normalized Diluted EPS | -0.61% | 26.14% | -- | -- | -- |
| Average Basic Shares Outstanding | 16.63% | 10.57% | -- | -- | -- |
| Average Diluted Shares Outstanding | 19.52% | 13.46% | -- | -- | -- |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |